Currently Viewing:
The International Society for Pharmacoeconomics and Outcomes Research
Value Assessment Frameworks Should Represent a Spectrum of Patient Preferences
September 08, 2017
Dr Patricia Danzon: Learning From European Health Systems
August 30, 2017
Dr Ilene Hollin: One-Size-Fits-All to Value Doesn't Work
August 23, 2017
Dr Patricia Danzon Highlights European Examples of Restraining Drug Prices
August 16, 2017
Dr Ilene Hollin Outlines Differing Definitions of Value
August 09, 2017
Dr Patricia Danzon: Cost Effective Doesn't Mean Affordable
August 03, 2017
Currently Reading
Dr Michael Sherman on Performance-Based Risk-Sharing Agreements
July 28, 2017
Dr Steve Pearson on Using Health Technology Assessment to Guide Decision Making
July 23, 2017
Dr Gail Wilensky: Increased Competition a Better Drug Pricing Solution Than Cost Controls
July 16, 2017
Dr Steve Pearson on Data Needed to Evaluate Clinical and Economic Effects of New Therapies
July 14, 2017
Dr David Cutler: Trump Administration's Attention Not on Value-Based Purchasing
July 09, 2017
Dr Gail Wilensky on the Likelihood of Continuing Value-Based Reimbursement Demonstrations
July 06, 2017
Dr Steve Pearson: Patient Perspectives Guide ICER Value Framework Development
July 04, 2017
Dr Scott Ramsey Addresses the Need for Differential Pricing Structures for Drugs
July 02, 2017
Dr Gail Wilensky Raises Questions About Medicaid's Matching Grant Structure
June 25, 2017
Dr Steve Pearson Explains How ICER Price Benchmarks Align Cost With Patient Benefits
June 22, 2017
Dr David Cutler Discusses Opportunities for Bipartisan ACA Reform
June 20, 2017
Dr Scott Ramsey on Challenges of Determining Cost Effectiveness of Novel Cancer Treatments
June 19, 2017
Dr Steve Pearson's Outlook on the Ongoing Updates to ICER's Value Framework
June 18, 2017

Dr Michael Sherman on Performance-Based Risk-Sharing Agreements

Michael Sherman, MD, chief medical officer at Harvard Pilgrim Health Care, discusses the challenges of moving towards performance-based risk-sharing agreements and where they would work best for certain treatments.


Michael Sherman, MD, chief medical officer at Harvard Pilgrim Health Care, discusses the challenges of moving towards performance-based risk-sharing agreements and where they would work best for certain treatments.

Transcript (slightly modified)

What are the challenges of negotiating performance-based risk-sharing agreements?

We’ve been doing risk-sharing agreements with providers for many years. Pharmaceuticals stand out as being a bit different than all other parts of the care delivery continuum. The fact is there is an existing status quo and just as it’s hard to move away from fee-for-service with providers, moving from pay-for-pills to paying for outcomes feels a bit hard. Part of the reason is that pharmaceutical companies haven’t felt the need or the urgency to move in this direction. Now that we have some successes, I think many of them are seeing them as an opportunity, not just as a threat.

Are there certain treatments or disease states where performance-based, risk-sharing agreements work best?

Absolutely, one of the constraints is the disease state. First, there have to be diseases where there is an outcome measure, like reduced cholesterol, like improved hemoglobin A1C for diabetes, like reduced hospitalization. They need to be things where there are objective measures and where they are not impossible or hard to collect. Also, where there is a clear relationship between the treatment and that measure. For cases where there are multiple drug regimens it may be complicated, in cases where the natural course of the disease may be variable it may be hard to do this, and where the impact is many years outed, it’s very hard to do. I estimate there is probably 20% to 25% of drugs where this is a good approach.

 
Copyright AJMC 2006-2017 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!